Opinion|Videos|February 24, 2025
Key Takeaways for Patient-Centered Management of Atopic Dermatitis
Author(s)Raj Chovatiya, MD, PhD, MSCI
The panelist discusses how systemic atopic dermatitis therapies now emphasize targeted biologics and Janus kinase inhibitors, requiring personalized approaches, comprehensive monitoring, and holistic patient management.
Advertisement
Episodes in this series
Video content above is provided by the following:
- Based on our discussion, what key insights or new perspectives could you share regarding treatment considerations for systemic therapies for atopic dermatitis?
- What take-home messages or practice pearls do you have for clinicians treating patients with atopic dermatitis?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria
3
10 Skin Cancer Exam Tips
4
Dermatology Times Conferences & Meetings Calendar: September 2026
5